Primary hemangiosarcoma of the iliopsoas muscle eliciting a peripheral neuropathy

Journal of the American Animal Hospital Association

Volumn 36, Issue 2, 2000, Pages 163-167

  Tucker, Douglas W ^a   Olsen, Dennis ^a   Kraft, Susan L ^a   Andrews, Gordon A ^a   Gray, Andrew P ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSARCOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; BACK; CASE REPORT; DOG; DOG DISEASE; HINDLIMB; MALE; MUSCLE TUMOR; PARAPLEGIA; PATHOLOGY; PERIPHERAL NEUROPATHY;

ANIMALS; DOG DISEASES; DOGS; HEMANGIOSARCOMA; HINDLIMB; LUMBOSACRAL REGION; MALE; MUSCLE NEOPLASMS; PARAPLEGIA; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0034150513     PISSN: 05872871     EISSN: None     Source Type: Journal    
DOI: 10.5326/15473317-36-2-163     Document Type: Article

References (22)

1. Oksanen A. Haemangiosarcoma in dogs. J Comp Path 1978;88:585-95.
2. Pulley LT, Stannard AA. Tumors of the skin and soft tissues. In: Moulton JE, ed. Tumors of domestic animals. 3rd ed. Berkeley: Univ Calif Press. 1990:47-8.
3. Brown NO. Hemangiosarcomas. Vet Clin N Am 1985;15(3):569-73.
4. Hosgood G. Canine hemangiosarcoma. Comp Cont Ed Pract Vet 1991;13(7):1065-75.
5. Hammer AS, Couto CG. Diagnosing and treating hemangiosarcoma. Vet Med 1992;87(3):188-201.
6. Prymach C, McKee LJ, Goldschmidt MH, Glickman LT. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma in dogs: 217 cases (1985). J Am Vet Med Assoc 1988;193(6): 706-12.
7. Brown NO, Patnaik AK, MacEwen EG. Canine hemangiosarcoma: retrospective analysis of 104 cases. J Am Vet Med Assoc 1985;186(1):56-8.
8. Parchman MB, Crameri FM. Primary vertebral hemangiosarcoma in a dog. J Am Vet Med Assoc 1989;144(1):79-81.
9. Ng CY, Mills JN. Clinical and haematologic features of haemangiosarcoma in dogs. Aust Vet J 1985;62(1):1-4.
10. Hammer AS, Couto G, Filppi J, Getzy D. Shank K. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin. and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Int Med 1991;5(3):160-5.
11. Sorenmo KU, Jegium KA, Helfand SC. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. J Vet Int Med 1993;7(6):370-6.
12. Ogilvie GK, Powers BE, Mallinckrodt CH, Withrow SJ. Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Int Med 1996;10(6):379-84.
13. Waters DJ, Hayden DW, Walter PA. Intracranial lesions in dogs with hemangiosarcoma. J Vet Int Med 1989;3(4):222-30.
14. Aronsohn M. Cardiac hemangiosarcoma in the dog: a review of 38 cases. J Am Vet Med Assoc 1985;187(9):922-6.
15. Hammer AS, Couto CG, Swardson C, Getzy D. Hemostatic abnormalities in dogs with hemangiosarcoma. J Vet Int Med 1991;5(1):11-4.
16. Hargis AM, Feldman BF. Evaluation of hemostatic defects secondary to vascular tumors in dogs: 11 cases (1983-1988). J Am Vet Med Assoc 1991;198(5):891-4.
17. Holt D, Van Winkle T, Schelling C, Prymark C. Correlation between thoracic radiographs and postmortem findings in dogs with hemangiosarcoma: 77 cases (1984-1989). J Am Vet Med Assoc 1992;200(10):1535-9.
18. Hammer AS, Bailey MQ, Sagartz JE. Retrospective assessment of thoracic radiographic findings in metastatic canine hemangiosarcoma. Vet Rad & Ultrasound 1993;34(4):235-8.
19. Ragazzino MW, Chisin R, Rosenthal DI. MR imaging of the musculoskeletal system. In: Eddman RR, Hesselink JR, eds. Clinical magnetic resonance imaging, Philadelphia: WB Saunders, 1990:1097-130.
20. Gentili A, Recht MP. Musculoskeletal tumors. In: Haaga JR. Lanzieri CF, Sartoris DJ, Zerhouni EA, eds, Computed tomography and magnetic resonance imaging of the whole body. St. Louis: Mosby, 1994 1407-26.
21. Chang AE, Matory YL, Dwyer AJ. et al. Magnetic resonance imaging versus computed tomography in the evaluation of soft tissue tumors of the extremities. Ann Surg 1987;205:340-8.
22. Vail DM, MacEwan EG, Kurzman ID, et al. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Can Res 1995;1:1165-70.